Metastatic Colorectal Cancers Completed Phase 1 Trials for Oxaliplatin (DB00526)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00536809Phase I/II Study of Lapatinib in Combination With Oxaliplatin and Capecitabine in Subjects With Advanced Colorectal CancerTreatment
NCT01571024BKM120 + mFOLFOX6 in Advanced Solid Tumors With Expansion Cohort Pancreatic CancerTreatment
NCT00920868XAD - Xelox (Capecitabine + Oxaliplatin) + Bevacizumab + DasatinibTreatment